Phenytoin: a new look at its anti-epileptic mechanism and adverse effects
Szkilnik, R.; Brus, R.
Neurologia i Neurochirurgia Polska 22(3): 246-251
1988
ISSN/ISBN: 0028-3843 PMID: 3065668 Document Number: 322693
Document emailed within 1 workday
Related Documents
Janiec, W.; Pietryka, B.; Sliwiński, L.; Leszczyńska, J. 1985: Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids Wiadomosci Lekarskie 38(22): 1613-1619Janiec, W.; Pietryka, B.; Pytlik, M.; Leszczyńska, J. 1985: Adverse effects of non-steroidal anti-inflammatory drugs. II. Adverse effects of heterocyclic enols Wiadomosci Lekarskie 38(24): 1745-1750
Sirisamut, T.; Chinvarun, Y.; Tantisira, M.H. 2014: Effects of phenytoin and valproic acid on cognitive functions of Thai epileptic patients: a pilot study Journal of the Medical Association of Thailand 97(Suppl 2): S77-S87
Devilat, M.; Blumel, J.E. 1991: Adverse effects of valproic acid in epileptic infants and adolescents Revista Chilena de Pediatria 62(6): 362-366
Szczechowski, L.; Marczewska, E. 1987: Role of membrane receptors in the pathogenesis of epilepsy and in the mechanism of action of anti-epileptic drugs Polski Tygodnik Lekarski 42(16): 485-488
Szczechowski, L.; Lenart-Grabowska, M.; Marczewska, E. 1989: The role of adenosine cyclic monophosphate (c-AMP) in the pathogenesis of epilepsy and the mechanism of the action of anti-epileptic drugs Wiadomosci Lekarskie 42(13-15): 881-883
Campistol, J. 2002: Teratogenic effects of epilepsy and anti epileptic drugs Revista de Neurologia 35(Suppl 1): S135-S143
Ahuja, S.R.; Karande, S.; Kulkarni, M.V. 2000: Cerebellar atrophy in an epileptic child: is it due to phenytoin? Journal of Postgraduate Medicine 46(4): 278-279
Gatti, G.; Perucca, E.; Caravaggi, M.; Poloni, M.; Frigo, G.M.; Crema, A. 1977: Pharmacokinetics of phenytoin following intravenous administration in epileptic patients Il Farmaco; Edizione Pratica 32(9): 470-474
Wässer, S.; Walther, H.; Jalinski, W.; Scheidemann, I.; Bergmann, L. 1980: Medication reliability of epileptic children treated with phenytoin Zeitschrift für Arztliche Fortbildung 74(23): 1106-1110
Sandyk, R. 1981: Choreo-athetosis induced by phenytoin in an epileptic child. A case report South African Medical Journal 60(16): 627-628
Liamsuwan, S.; Jaiweerawattana, U. 2011: Correlation between serum and salivary phenytoin concentrations in Thai epileptic children Journal of the Medical Association of Thailand 94(Suppl 3): S172-S177
Forfang, K.; Lippestad, C.T. 1971: Adverse effects of lidocaine as an anti-arrhythmic drug Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 710-713
Wässer, S.; Jalinski, W.; Quednow, B.; Walther, H. 1984: Initial therapeutic results in epileptic children with and without serum-controlled phenytoin treatment Padiatrie und Grenzgebiete 23(1): 11-14
Ostensen, M. 1990: Adverse effects of non-steroidal anti-inflammatory agents on the central nervous system Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(7): 856
Galas-Zgorzalewicz, B.; Borysewicz-Lewicka, M.; Zgorzalewicz, M.; Borowicz-Andrzejewska, E. 1996: The effect of chronic carbamazepine, valproic acid and phenytoin medication on the periodontal condition of epileptic children and adolescents Functional Neurology 11(4): 187-193
De Romanis, F.; Sopranzi, N. 1990: Bombesin, dermorphin, physalaemin and sauvagine: effects on superficial and depth EEG tracings in epileptic and non-epileptic rats La Clinica Terapeutica 133(1): 35-38
Otoom, S.; Bakhiet, M.; Khan, A.; Sequeira, R. 2006: Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders Neuro Endocrinology Letters 27(1-2): 85-88
Kariks, J.; Perry, S.W.; Wood, D. 1971: Serum folic acid and phenytoin levels in permanently hospitalized epileptic patients receiving anticonvulsant drug therapy Medical Journal of Australia 2(7): 368-371
Stricker, B.H.; Ottervanger, J.P.; van der Klauw, M.M. 1994: Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993 Nederlands Tijdschrift Voor Geneeskunde 138(42): 2110-2113